Nurix Therapeutics Advances Clinical and Preclinical Pipeline and Outlines 2022 Catalysts

NEXT STORY
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
PREV STORY
Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Inovio Presents Progression Free Survival & PSA Doubling Time Improvements in Prostate Cancer Patients Treated with INO-5150

Study Results Presented at a Major European Cancer Conference (ESMO) PLYMOUTH MEETING, Pa., Oct. ...

author_avatar
NASDAQ Market News

TESARO Announces Expanded Development Program for Niraparib Focused on the Treatment of Front-Line Metastatic Ovarian and Lung Cancers and Metastatic Breast Cancer

Expanded niraparib ovarian cancer program intended to potentially transform the treatment of front-line ovarian ...

author_avatar
NASDAQ Market News

Solid Biosciences Welcomes Industry Expert Dr. Martin Freed To Its Board Of Directors

Ilan Ganot, Co-Founder and CEO, Assumes Additional Role of PresidentGilad Hayeem, Co-Founder, President and ...

author_avatar
NASDAQ Market News